vimarsana.com
Home
Live Updates
Preliminary Ongoing Results with CYT-0851 in Combination wit
Preliminary Ongoing Results with CYT-0851 in Combination wit
Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety Profile
- CYT-0851 has demonstrated early activity in combination with capecitabine or gemcitabine in advanced solid tumors and a generally well tolerated safety profile in a heavily pretreated population of... | June 3, 2023
Related Keywords
Chicago ,
Illinois ,
United States ,
American ,
Markus Renschler ,
Linkedin ,
Exchange Commission ,
American Society Of Clinical Oncology ,
Cyteir Therapeutics Inc ,
Twitter ,
Cyteir Therapeutics ,
Monocarboxylate Transporter ,
Advanced Solid ,
Clinical Oncology ,
Chief Executive Officer ,
Annual Report ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Gas ,
Remonstrated ,
Early ,
Activity ,
N ,
Combination ,
Ith ,
Capecitabine ,
Dr ,
Gemcitabine ,
Dvanced ,
Olid ,
Rumors ,
End ,
Igenerally ,
Fell ,
Ctolerated ,
Safety ,
Profile ,
Heavily ,
Pretreated ,
Opulation Cyt Us23284p1030 ,